ICON is a true extension of Biotech by demonstrating a clear understanding of the needs of Biotech companies in terms of flexibility, proactiveness, and responsiveness

Approximately 30% of ICON’s business is derived from Biotech “stand alone safety”

ICON’s U.S. Business Development team includes a BioEast and a BioWest division with 6 sales professionals supporting the Biotech businesse

ICON’s European biotech team is being expanded and is expected to grow over the next year

For early Phase studies, the ICON Development Solutions division offers Phase I and Proof-of-Concept clinical operations services
• Strategic input into study designs and development plans
• Regulatory strategy consulting
• Non-clinical consulting and management support (CMC and preclinical)

In the U.S., ICON has invested in four West Coast offices which offer support to Biotech
• Northern California: San Francisco, Redwood City
• Southern California: San Diego and Irvine